1-3 of 3
Frances Zhao, MS
Close
Sort by
Journal Articles

Antitumor Activity Of The Glutaminase Inhibitor CB-839 In Hematological Malignances

Francesco Parlati, PhD, Shoshana Bromley-Dulfano, BS, Susan Demo, PhD, Julie Janes, MS, Matt Gross, BS, Evan Lewis, PhD, Andy MacKinnon, PhD, Mirna Rodriguez, BS, Jinfu Yang, PhD, Frances Zhao, MS, Mark Bennett, PhD
Journal: Blood
Blood (2013) 122 (21): 4226.
https://doi.org/10.1182/blood.V122.21.4226.4226
Published: 2013
Journal Articles

Genetically Reengineered K562 Cells Significantly Expand Cord Blood (CB) Natural Killer (NK) Cells Ex-Vivo Expanded with Increased NK Cell Activation and Cytolytic Activity Both In-Vitro and In-Vivo: Potential Use In Adoptive Cellular Immunotherapy (ACI)

Michele Levin, MD, Janet Ayello, MS, MT(ASCP), Frances Zhao, MS, Andrew Stier, Lauren Tiffen, William Quish, Carmella vandeVen, MA, Laxmi V. Baxi, MD, Jessica Hochberg, MD, Mitchell S. Cairo, MD
Journal: Blood
Blood (2010) 116 (21): 3928.
https://doi.org/10.1182/blood.V116.21.3928.3928
Published: 2010
Journal Articles

Romedepsin (RM), a Histone Deacytelase Inhibitor (HDACi), Significantly Increases the Expression of NKG2D Ligands, MIC A/B, In Pediatric Leukemia/Lymphoma Cells (LL), Resulting In Enhanced In Vitro and In Vivo NK Cytotoxicity In NOD-SCID Mice: Translational Approach for Adoptive NK Cell Targeted Immunotherapy

Prakash Satwani, MD, Aniket Saha, MD, Sejal Bavishi, BS, Frances Zhao, MS, Janet Ayello, MS, MT(ASCP), Carmella van de Ven, MA, Mitchell S. Cairo, MD
Journal: Blood
Blood (2010) 116 (21): 4297.
https://doi.org/10.1182/blood.V116.21.4297.4297
Published: 2010